Tashkent, Uzbekistan (UzDaily.com) -- Today, on 30 September, 1,458,820 doses of ZF-UZ-VAC2001 vaccine produced on the basis of Jurabek Laboratories JV LLC were transferred to representatives of the Sanitary and Epidemiological Surveillance and Health Service of the Republic of Uzbekistan.

To date, the joint venture has produced a total of 7 million doses of vaccine, with subsequent doses being delivered in stages to vaccination sites. The ceremony was attended by Minister of Innovative Development Ibrohim Abdurakhmonov, Deputy Head of the Sanitary and Epidemiological Welfare and Public Health Service Nurmat Otabekov, First Deputy Director of the Agency for the Development of the Pharmaceutical Industry Dilshod Akbarov. 

The Jurabek Laboratories LLC joint venture produces the vaccine under a cooperation agreement with the Chinese company Anhui Jifei Longcom Biopharmaceutical Co., Ltd. The organization of production is the result of cooperation between Uzbek and Chinese scientists and virologists.

The ZV-UZ-VAS2001 vaccine against COVID-19 was developed by Jifei Longcom Biopharmaceutical in cooperation with the Institute of Microbiology of the Chinese Academy of Sciences, the Center for Advanced Technologies under the Ministry of Innovative Development of the Republic of Uzbekistan and the Research Institute of Virology of the Ministry of Health of the Republic of Uzbekistan. According to the results of the 3rd phase of clinical trials, the effectiveness of this vaccine is 81.76% after 3 doses for all strains and 92.93% against the "British" strain.

The production of the ampouled form of the drug was carried out on the basis of the original substance produced at the biopharmaceutical enterprise Anhui Jifei Longcom Biopharmaceutical Co., Ltd.